News

The group comprising European experts is set to advice on any scientific and regulatory matters to conduct the research and development of medicines or vaccines against the mosquito-borne

CytRx has received the first $25 million of financing under the loan and security agreement. The proceeds will be used for pre-commercialization and manufacturing activities for aldoxorubicin, clinical

The benchtop GeneReader combines with other Qiagen NGS products to provide the first seamless, fully automated Sample to Insight workflow. Volpi optimized the GeneReader’s automated imaging module at

This clinical hold impacts part of the clinical work currently being conducted under the IND and will also affect planned clinical trials. Under the partial clinical hold, clinical

Under this agreement Septodont will promote SPRIX (ketorolac tromethamine) Nasal Spray exclusively to dentists in the United States using its focused specialty sales force. Under the terms of

People with hypercholesterolaemia and mixed dyslipidaemiai have high concentrations of cholesterol in their blood. In primary non-familial hypercholesterolaemia, a number of genes interact with dietary and other factors

Under the agreement, Lonza will manufacture material at multiple sites, including Slough (UK), Visp (CH) and Nansha (CN). Retinal diseases, such as age-related macular degeneration (AMD), cause blindness

The parties will work on the part B portion of the MoveDMD clinical trial of CAT-1004. MDA will provide funding required to transport patients who need to travel

The agency sent a complete response letter to Vertex, stating that it cannot approve the company’s supplemental new drug application (sNDA) in its current form. Vertex plans to